Mendel AI

Mendel AI is an advanced clinical AI tool that deciphers clinical data with clinician-like logic. It offers a fully integrated suite of clinical-specific data processing products, combining OCR, de-identification, and clinical reasoning to interpret medical records. Users can ask questions in plain English and receive accurate answers from health records in seconds. Mendel's technology goes beyond traditional AI by understanding patient-level data and ensuring consistency and explainability of results in healthcare.

ICD AI is an advanced artificial intelligence tool designed to assist healthcare professionals in accurately assigning diagnostic codes to patient records. The tool utilizes machine learning algorithms to analyze medical data and suggest appropriate ICD codes, streamlining the coding process and reducing errors. With its user-friendly interface and robust features, ICD AI is revolutionizing medical coding practices and improving efficiency in healthcare facilities.

Owkin is a full-stack AI biotech company that integrates the best of human and artificial intelligence to deliver better drugs and diagnostics at scale. By understanding complex biology through AI, Owkin identifies new treatments, de-risks and accelerates clinical trials, and builds diagnostic tools to reduce time to impact for patients.

Medcol.io is a clinical AI assistant designed to support healthcare professionals in making informed decisions by providing evidence-based recommendations and insights. The platform leverages advanced algorithms and medical data analysis to assist in diagnosing diseases, suggesting treatment plans, and predicting patient outcomes. With a user-friendly interface and real-time updates, Medcol.io aims to streamline the clinical decision-making process and improve patient care.

Tempus is an AI-enabled precision medicine company that brings the power of data and artificial intelligence to healthcare. With the power of AI, Tempus accelerates the discovery of novel targets, predicts the effectiveness of treatments, identifies potentially life-saving clinical trials, and diagnoses multiple diseases earlier. Tempus's innovative technology includes ONE, an AI-enabled clinical assistant; NEXT, a tool to identify and close gaps in care; LENS, a platform to find, access, and analyze multimodal real-world data; and ALGOS, algorithmic models connected to Tempus's assays to provide additional insight.

Genie TechBio is the world's first AI bioinformatician, offering an LLM-powered omics analysis software that operates entirely in natural language, eliminating the need for coding. Researchers can effortlessly analyze extensive datasets by engaging in a conversation with Genie, receiving recommendations for analysis pipelines, and obtaining results. The tool aims to accelerate biomedical research and empower scientists with newfound data analysis capabilities.

Unlearn.ai is an AI-powered digital twins solution provider that optimizes clinical trials. Their TwinRCTs enable confident and quick clinical trials in various medical fields such as neuroscience, immunology, and metabolic diseases. By creating digital twins of patients, Unlearn.ai enhances the power and efficiency of clinical trials, attracting study participants and making confident decisions from early to late-stage studies.

Tempus is an AI-enabled precision medicine company that brings the power of data and artificial intelligence to healthcare. With the power of AI, Tempus accelerates the discovery of novel targets, predicts the effectiveness of treatments, identifies potentially life-saving clinical trials, and diagnoses multiple diseases earlier. Tempus' innovative technology includes ONE, an AI-enabled clinical assistant; NEXT, which identifies and closes gaps in care; LENS, which finds, accesses, and analyzes multimodal real-world data; and ALGOS, algorithmic models connected to Tempus' assays to provide additional insight.

The website OpenLife.ai is an AI tool that focuses on various aspects of healthcare, including medical AI, ambient clinical intelligence, clinical documentation integrity, healthcare analytics, patient engagement, radiology solutions, and more. It offers insights, news, and resources related to the application of artificial intelligence in the healthcare industry.

neurons.bio is an AI application that offers a unique collection of over 100 AI agents designed for drug development, medicine, and life science research. These agents perform specific tasks efficiently, retrieve data from various sources, and provide insights to accelerate research processes. The platform aims to revolutionize drug discovery and development by integrating cutting-edge LLM technology with domain-specific agents, reducing research costs and time to clinic.

Cosign AI is an AI application that optimizes clinical practices by automating clinical documentation through an ambient scribe. The tool transforms conversations and dictations into clinical notes using large language models and customizable templates. It prioritizes HIPAA compliance and data security, ensuring a secure infrastructure for storing and processing protected health information. Clinicians can save time, reduce burnout, and improve note quality with this innovative solution.

Modality.AI is an AI application that has developed an automated, clinically validated system to assess neurological and psychiatric states both in clinic and remotely. The platform utilizes conversational AI to monitor conditions accurately and consistently, allowing researchers and clinicians to review data in near real-time and monitor treatment response over time. Modality.AI collaborates with world-class AI/Machine Learning experts and leading institutions to provide a HIPAA-compliant system for assessing various indications such as ALS, Parkinson's, depression, autism, Huntington's Disease, schizophrenia, and mild cognitive impairment. The platform enables convenient monitoring at home through streaming and analysis of speech and facial responses, without the need for special software or apps. Modality.AI is accessible on various devices with a browser, webcam, and microphone, offering a new approach to efficient and cost-effective clinical trials.

Profundo is an AI-powered research assistant that automates data collection, analysis, and reporting. It enables users to conduct in-depth research on various topics efficiently and accurately. With cutting-edge AI algorithms, Profundo minimizes errors, maximizes productivity, and provides user-friendly interface for seamless integration with existing tools. Trusted by professionals, Profundo is used for self-study, content creation, academic research, industry analysis, and more.

BetterMedicine is an AI software designed for cancer diagnostics and detection. It offers AI-powered solutions to enhance patient outcomes and drive efficiency in radiology workflows. The software is expertly designed by medical professionals and AI specialists, providing trusted and clinically validated solutions. BetterMedicine aims to address inefficiencies in radiology by integrating AI-powered software for detecting lesions on CT scans seamlessly into the workflow, thereby improving efficiency and reducing the risk of oversight. The application focuses on improving patient outcomes, reducing errors, and enhancing the wellbeing of radiology professionals.

MedReport AI is an AI-powered healthcare solution that specializes in generating efficient medical reports for healthcare providers. The application utilizes advanced AI technology to transform existing notes into Medicare updates, progress notes, discharge summaries, referrals, and more instantly. It aims to streamline the reporting process, reduce documentation time, and improve efficiency in delivering patient care. MedReport AI is trusted by healthcare providers in Australia for its ability to cut administrative time significantly and provide accurate clinical documentation.

Glass is an AI-powered clinical decision support platform that empowers clinicians by providing differential diagnoses and drafting clinical plans based on patient summaries. The platform combines a large language model with evidence-based clinical guidelines to assist clinicians in making informed decisions. Glass Health aims to optimize the practice of medicine, improve patient care, increase diagnostic accuracy, implement evidence-based treatment, enhance medical education, eliminate burnout, accelerate health equity, and improve patient outcomes globally.

Mendel AI is an advanced clinical AI tool that deciphers clinical data with clinician-like logic. It offers a fully integrated suite of clinical-specific data processing products, combining OCR, de-identification, and clinical reasoning to interpret medical records. Users can ask questions in plain English and receive accurate answers from health records in seconds. Mendel's technology goes beyond traditional AI by understanding patient-level data and ensuring consistency and explainability of results in healthcare.

Unlearn.ai is an AI-powered digital twins solution provider that optimizes clinical trials. Their TwinRCTs enable confident and quick clinical trials in various medical fields such as neuroscience, immunology, and metabolic diseases. By creating digital twins of patients, Unlearn.ai enhances the power and efficiency of clinical trials, attracting study participants and making confident decisions from early to late-stage studies.

PMcardio is an AI-powered ECG interpretation platform that offers accurate diagnosis of cardiovascular diseases within seconds. It provides rapid referral to specialists, detects occlusion myocardial infarction, and identifies reduced left ventricular ejection fraction from 12-lead ECGs. PMcardio enhances clinical decision-making, standardizes ECG reports, and ensures data security. The platform is designed for both individuals and organizations in the healthcare sector, offering seamless coordination and high accuracy in diagnostics.

Tempus is an AI-enabled precision medicine company that brings the power of data and artificial intelligence to healthcare. With the power of AI, Tempus accelerates the discovery of novel targets, predicts the effectiveness of treatments, identifies potentially life-saving clinical trials, and diagnoses multiple diseases earlier. Tempus's innovative technology includes ONE, an AI-enabled clinical assistant; NEXT, a tool to identify and close gaps in care; LENS, a platform to find, access, and analyze multimodal real-world data; and ALGOS, algorithmic models connected to Tempus's assays to provide additional insight.

Oncora Medical is a healthcare technology company that provides software and data solutions to oncologists and cancer centers. Their products are designed to improve patient care, reduce clinician burnout, and accelerate clinical discoveries. Oncora's flagship product, Oncora Patient Care, is a modern, intelligent user interface for oncologists that simplifies workflow, reduces documentation burden, and optimizes treatment decision making. Oncora Analytics is an adaptive visual and backend software platform for regulatory-grade real world data analytics. Oncora Registry is a platform to capture and report quality data, treatment data, and outcomes data in the oncology space.

BenevolentAI is a leader in applying advanced AI to accelerate biopharma drug discovery blending science and technology with a focus on finding solutions for complex diseases. We empower both biopharmaceutical companies and our internal scientists to harness the full potential of data and AI to accelerate the next generation of scientific advances. We have built our AI-enabled drug discovery engine to drive a revolution in drug discovery. The Benevolent Platform™ unlocks the power of a vast biomedical data landscape to provide a multidimensional representation of human biology across all diseases. We believe this approach will improve the probability of clinical success, and help us deliver life-changing treatments to patients – because it matters.

The National Cancer Institute's Center for Biomedical Informatics and Information Technology (CBIIT) provides a comprehensive suite of tools, resources, and training to support cancer data science research. These resources include data repositories, analytical tools, data standards, and training materials. CBIIT also develops and maintains the NCI Thesaurus, a comprehensive vocabulary of cancer-related terms, and the Cancer Data Standards Registry and Repository (caDSR), a repository of cancer data standards. CBIIT's mission is to accelerate the pace of cancer research by providing researchers with the tools and resources they need to access, analyze, and share cancer data.

Modality.AI is an AI application that has developed an automated, clinically validated system to assess neurological and psychiatric states both in clinic and remotely. The platform utilizes conversational AI to monitor conditions accurately and consistently, allowing researchers and clinicians to review data in near real-time and monitor treatment response over time. Modality.AI collaborates with world-class AI/Machine Learning experts and leading institutions to provide a HIPAA-compliant system for assessing various indications such as ALS, Parkinson's, depression, autism, Huntington's Disease, schizophrenia, and mild cognitive impairment. The platform enables convenient monitoring at home through streaming and analysis of speech and facial responses, without the need for special software or apps. Modality.AI is accessible on various devices with a browser, webcam, and microphone, offering a new approach to efficient and cost-effective clinical trials.

Sully.ai is the #1 all-in-one AI solution designed to save doctors' time by creating superhuman doctors. The platform offers a comprehensive set of features such as pre-visit screening, decision support, scribing, diagnosis assistance, clinical planning, and post-visit automations. Sully.ai is an automation platform that works seamlessly with Electronic Medical Records (EMR) systems, providing personalized and multilingual support for healthcare professionals. The AI model is HIPAA compliant and trained on real-life doctor encounters to enhance decision-making and streamline administrative tasks. With proven results in reducing repetitive tasks and improving efficiency, Sully.ai aims to transform healthcare delivery by empowering doctors to focus on patient care.

Neural Consult is a cutting-edge AI-powered medical education platform that offers personalized learning tools to empower medical students. The platform provides unlimited board questions, Anki cards, clinical simulations, and more, tailored to individual study needs. With features like question generation, lecture summaries, differential diagnosis, and AI-powered case simulations, Neural Consult revolutionizes the way medical students learn and prepare for exams. Trusted by students at top medical schools, Neural Consult aims to enhance clinical reasoning, memorization skills, and overall learning efficiency through innovative AI technology.

Neuralink is a pioneering brain-computer interface (BCI) application that aims to redefine human capabilities by creating a generalized brain interface to restore autonomy to individuals with unmet medical needs. The application focuses on developing fully implantable BCIs that allow users, particularly those with quadriplegia, to control computers and mobile devices using their thoughts. Neuralink's innovative technology includes advanced chips, biocompatible enclosures, and surgical robots for precise implantation. The application prioritizes safety, accessibility, and reliability in its engineering process, with future goals of restoring vision, motor function, and speech capabilities.

Medical Brain is an AI-powered clinical assistant designed for both patients and providers. It engages with users to identify health risks and care gaps early, providing actionable insights and guidance to improve outcomes and intercept high-cost ER visits. The platform monitors patients 24/7, aggregates and understands all patient data, and generates real-time actions based on AI clinical decision support and automation. Medical Brain incorporates evidence-based best practices in various clinical modules and continuously learns from user experiences to enhance efficiency and intelligence.

Health Imaging is an AI-powered platform that focuses on providing cutting-edge solutions in medical imaging and healthcare management. The platform offers a wide range of features and tools that leverage artificial intelligence to enhance diagnostic accuracy, streamline workflows, and improve patient care. From advanced imaging technologies to AI-based training solutions, Health Imaging is at the forefront of innovation in the healthcare industry.

Simbo AI is a Gen AI platform designed for healthcare enterprises, offering autonomous applications for medical practice automation. It combines LLM and symbolic knowledge bases to provide hallucination-free responses. The platform is fully controllable, consistent, secure, and responsible, ensuring accurate and reliable AI interactions. Simbo AI utilizes Symbolic RAG technology with Lossless NLU for exact search and fact-checking capabilities. It aims to automate medical practices, reduce costs, and improve patient care, ultimately enhancing the lives of doctors and patients.

Mendel AI is an advanced clinical AI tool that deciphers clinical data with clinician-like logic. It offers a fully integrated suite of clinical-specific data processing products, combining OCR, de-identification, and clinical reasoning to interpret medical records. Users can ask questions in plain English and receive accurate answers from health records in seconds. Mendel's technology goes beyond traditional AI by understanding patient-level data and ensuring consistency and explainability of results in healthcare.

Cercle is an AI platform that advances healthcare for women by transforming healthcare data into real-time, high-quality insights. The platform caters to women's healthcare providers, payors, and pharma companies, helping them run more efficient businesses and provide personalized care. Cercle's Biomedical Graph unlocks insights at unprecedented speed and accuracy, optimizing patient care and improving outcomes in areas such as assisted reproduction and fertility processes.

SOMA is a Research Automation Platform that accelerates medical innovation by providing up to 100x speedup through process automation. The platform analyzes medical research articles, extracts important concepts, and identifies causal and associative relationships between them. It organizes this information into a specialized database forming a knowledge graph. Researchers can retrieve causal chains, access specific research articles, and perform tasks like concept analysis, drug repurposing, and target discovery. SOMA enhances literature review efficiency by finding relevant articles based on causal chains and keywords specified by the user. It empowers researchers to focus on their research by saving up to 95% of the time spent on pre-processing documents. The platform offers freemium access with extended functionality for 14 days and advanced features available through subscription.

NeuProScan is an AI platform designed for the early detection of pre-clinical Alzheimer's from MRI scans. It utilizes AI technology to predict the likelihood of developing Alzheimer's years in advance, helping doctors improve diagnosis accuracy and optimize the use of costly PET scans. The platform is fully customizable, user-friendly, and can be run on devices or in the cloud. NeuProScan aims to provide patients and healthcare systems with valuable insights for better planning and decision-making.

Insight is an AI-powered medical research tool that serves as a research assistant for generating scientific summaries, hypotheses, experimental designs, and target identification. It empowers scientists to navigate literature, formulate hypotheses, and design experiments by utilizing peer-reviewed databases to provide reliable outputs. With integrated features like NIH PubMed access, NIH Reporter insights, and MYGENE & MYVARIANT deep dives, Insight streamlines the research process and accelerates discoveries in the medical field.

Biofourmis is a healthcare technology company that provides a connected technology platform for care delivery and drug development. The platform enables healthcare systems and pharmaceutical companies to deliver care and conduct clinical trials remotely, and to collect and analyze data to improve patient outcomes. Biofourmis's solutions have been shown to improve clinical, operational, and economic outcomes, such as reducing 30-day readmissions by 70%, detecting deterioration 21 hours sooner, and reducing cost of care by up to 38%.

AiCure provides a patient-centric eClinical trial management platform that enhances drug development through improved medication adherence rates, more powerful analysis and prediction of treatment response using digital biomarkers, and reduced clinical tech burden. AiCure's solutions support traditional, decentralized, or hybrid trials and offer flexibility to meet the needs of various research designs.

CompliantChatGPT is a HIPAA-compliant platform that allows users to utilize OpenAI's GPT models for healthcare-related tasks while maintaining data privacy and security. It anonymizes protected health information (PHI) by replacing it with tokens, ensuring compliance with HIPAA regulations. The platform offers various modes tailored to specific healthcare needs, including bloodwork analysis, PHI anonymization, diagnosis assistance, and treatment planning. CompliantChatGPT streamlines healthcare tasks, enhances productivity, and provides user-friendly assistance through its intuitive interface.

Freenome is a healthcare company that uses artificial intelligence and multiomics technology to detect cancer in its earliest stages through a simple blood draw. The company's mission is to make early cancer detection more accessible and affordable, and to improve the chances of successful treatment.

Nucleai is an AI-driven spatial biomarker analysis tool that leverages military intelligence-grade geospatial AI methods to analyze complex cellular interactions in a patient's biopsy. The platform offers a first-of-its-kind multimodal solution by ingesting images from various modalities and delivering actionable insights to optimize biomarker scoring, predict response to therapy, and revolutionize disease diagnosis and treatment.

neurons.bio is an AI application that offers a unique collection of over 100 AI agents designed for drug development, medicine, and life science research. These agents perform specific tasks efficiently, retrieve data from various sources, and provide insights to accelerate research processes. The platform aims to revolutionize drug discovery and development by integrating cutting-edge LLM technology with domain-specific agents, reducing research costs and time to clinic.